Conservative management of postsurgical chylothorax with octreotide.
Postsurgical chylothorax after lung resection has an important associated rate of morbidity and mortality, and a large proportion of cases require re-exploration. The most desirable and least aggressive option is conservative treatment. The use of octreotide seems to be associated with a higher rate of resolution without the need for surgical intervention. We present 4 cases in which this drug showed excellent efficacy and minimal adverse effects in the resolution of postsurgical chylothorax.
Gómez-Caro
Abel A
AA
Department of Thoracic Surgery, 12 de Octubre University Hospital, Andalucía Ctra KM 5.400, Madrid 28004, Spain. abelitov@yahoo.es
Moradiellos Diez
Francisco J
FJ
Marrón
Carmen F
CF
Larrú Cabrero
Emilio J
EJ
Martín de Nicolás
José L
JL
D000328:Adult; D000368:Aged; D002916:Chylothorax / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D011013:Pneumonectomy; D011183:Postoperative Complications; D013908:Thoracotomy
D005765:Gastrointestinal Agents; D015282:Octreotide